Contrast agents are chemicals, which are used to enhance the image effect to observe by injecting (or taking) into human tissue or organs. The density of contrast agents is higher or lower than surrounding tissue and this contrast can display images via some device.
Contrast agents are widely used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures.
In terms of volume, the production of contrast agents was about 242794 K Dose in 2015 and is anticipated to reach 329523 K Dose by 2021.
The contrast agents industry is a quite concentrated market with a few companies dominates the market. Bayer is the dominate producer of contrast agents, the production was 74476 K Dose in 2015, accounting for about 30.67% of the total amount, followed by GE Healthcare, with the production market share of 25.54 %. The top four companies occupied about 79.40 % production share of the market in 2015.
At present, in the foreign industrial developed countries the contrast agents industry is generally at a more advanced level, the world's large enterprises are mainly concentrated in the North America
Europe and Japan, accounted for most of the international market share. Meanwhile, these companies have more advanced equipment, strong R&D capabilities; the technical level is in a leading position.
The emerging markets (such as China, India) have relatively small scales. However, they have much higher market increasing growth than developed countries. They are the main growth areas in the global contrast agents market.
The sales volume shares of North America, Europe, Japan, China, India and Southeast Asia were 27.91%, 19.65%, 22.52%, 11.07%, 7.35% and 3.52%.
There are mainly two types of contrast agents: iodine preparations type and gadolinium preparations type. Currently, iodine preparations type is the main product and it occupied 81 % share in 2015.
X-CT accounted for the largest market with about 85.10 % market share of the global contrast agents consumption in 2015. Moreover, it is anticipated to grow at a CAGR of 4.92 % from 2016 to 2021. With over 13 % share in the contrast agents market, MRI was the second largest application market in 2015, and is anticipated to grow at a CAGR of 5.71% in terms of consumption volume, from 2016 to 2021.
Under the influence of raw material, market competitions and economic conditions, the price of contrast agents was fluctuant in recent years. Over the next few years, we predict that price will decline. As competition intensifies, prices gap between different brands will go narrowing.
The report offers detailed coverage of Contrast Agents industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Contrast Agents by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Contrast Agents market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Contrast Agents market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Bayer
GE Healthcare
Bracco Imaging
Guerbet Group
Hengrui Medicine
YRPG
Lantheus
BeiLu Pharma
At the same time, we classify Contrast Agents according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Iodine Preparations
Gadolinium Preparations
Others
Market by Application
X-CT
MRI
Others
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Contrast Agents market for the forecast period 2021 - 2025?
• What are the driving forces in the Contrast Agents market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Contrast Agents industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?